Drug profile · INN
empagliflozin + metformin
JARDIAMET 5 MG/500 MG
empagliflozin + metformin (JARDIAMET 5 MG/500 MG) is an FDA-listed pharmaceutical active ingredient. Associated with Boehringer Ingelheim Pty Ltd.
TGA: approved
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — empagliflozin + metformin
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.81
Quick answer
empagliflozin + metformin (JARDIAMET 5 MG/500 MG) is an FDA-listed pharmaceutical active ingredient. Associated with Boehringer Ingelheim Pty Ltd.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Pipeline programs
Frequently asked questions
What is empagliflozin + metformin?
empagliflozin + metformin (JARDIAMET 5 MG/500 MG) is an FDA-listed pharmaceutical active ingredient. Associated with Boehringer Ingelheim Pty Ltd.
What is the brand name for empagliflozin + metformin?
JARDIAMET 5 MG/500 MG is a marketed brand name for empagliflozin + metformin. Check FDA Drugs@FDA for the current US label holder and prescribing information.